Continuous Flow Manufacturing (CFM) is now widely recognized as an essential technology for the sustainability of the pharmaceutical industry. However, the pharmaceutical industry has been criticized as being slow adopters, due in part by a prior ambiguous regulatory landscape and continued high cost of entry.
In this webinar, we will discuss how these barriers are overcome at Asymchem by sharing some case studies where the benefits of CFM were realized in real-world applications to support drug product development.
Speaker: Mark McLaws, PhD, VP, CMC & Development, Asymchem